Michela Del Prete

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial

Michela Del Prete, François-Alexandre Buteau, Frédéric Arsenault et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 184 citations

Medicine, Nuclear Medicine, Oncology +17

Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors

Francesco Fiore, Michela Del Prete, Renato Franco et al. · Endocrine · 2014 · 132 citations

Medicine, Oncology, Surgery +17

Thyroid Nodules Treated with Percutaneous Radiofrequency Thermal Ablation: A Comparative Study

Antongiulio Faggiano, Valeria Ramundo, Angelo Pio Assanti et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 122 citations · Full text

Medicine, Oncology, Endocrine Surgery +14

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study

Michela Del Prete, François-Alexandre Buteau, Jean‐Mathieu Beauregard · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 118 citations

Medicine, Nuclear Medicine, Oncology +16

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

Mario Scartozzi, Riccardo Giampieri, Elena Maccaroni et al. · British Journal of Cancer · 2012 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17